rs200098356
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_172364.5(CACNA2D4):c.1882C>T(p.Arg628Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000348 in 1,613,112 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_172364.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CACNA2D4 | NM_172364.5 | c.1882C>T | p.Arg628Ter | stop_gained | 19/38 | ENST00000382722.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CACNA2D4 | ENST00000382722.10 | c.1882C>T | p.Arg628Ter | stop_gained | 19/38 | 1 | NM_172364.5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152214Hom.: 1 Cov.: 34
GnomAD3 exomes AF: 0.000780 AC: 194AN: 248596Hom.: 5 AF XY: 0.000815 AC XY: 110AN XY: 134918
GnomAD4 exome AF: 0.000342 AC: 500AN: 1460780Hom.: 7 Cov.: 31 AF XY: 0.000394 AC XY: 286AN XY: 726710
GnomAD4 genome AF: 0.000407 AC: 62AN: 152332Hom.: 1 Cov.: 34 AF XY: 0.000416 AC XY: 31AN XY: 74486
ClinVar
Submissions by phenotype
Retinal cone dystrophy 4 Pathogenic:1Uncertain:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 27, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 17, 2014 | The p.Arg628X variant in CACNA2D4 has not been previously reported in individuals with disease but has been identified in 0.06% (5/8296) of European American chromosomes and 0.03% (1/3876) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs200098356). This nonsense variant leads to a premature termination codon at position 628 which is predicted to lead to a truncated or absent protein. Complete loss of CACNA2D4 function has been reported in 2 siblings with autosomal recessive retinal cone dystrophy and a mouse model with complete loss of Cacna2d4 function displayed code-rod dysfunction (Wycisk 2006). In summary while the case report and mouse model indicate loss of CACNA2D4 function may be associated with retinal cone dystrophy, more data is needed to establish the role of CACNA2D4 in disease and therefore the clinical significance of the p.Arg628X variant is uncertain. - |
Abnormality of the eye Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2015 | Undetermined rare ocular disorder with frequency of less than eight patients - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 14, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at